Surgery Partners, Inc. (SGRY)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,860 | 2,225 | 2,539 | 2,743 | 3,114 | 3,309 | 3,366 | 3,373 |
| Operating profit | $m | 390 | 400 | ||||||
| Net profit | $m | -116 | -71 | -55 | -12 | -168 | -78 | -89 | 36 |
| EPS reported | $ | -0.61 | -0.69 | ||||||
| Operating cashflow per share | $ | 2.16 | 2.00 | ||||||
| Capex per share | $ | 0.62 | 0.55 | ||||||
| FCF per share | $ | 1.54 | 1.46 | ||||||
| Free cash flow | $m | 196 | 188 | ||||||
| Net debt | $m | 2,566 | 3,535 | ||||||
| Book value equity | $m | 1,713 | 1,671 | ||||||
| Book value per share | $ | 13.47 | 12.97 | ||||||
| Number of shares | m | 127.21 | 128.83 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.15 | 1.18 | ||||||
| P/S LTM | x | 0.59 | 0.58 | ||||||
| P/FCF LTM | x | 10.05 | 10.48 | ||||||
| EV/EBITDA LTM | x | 10.17 | 6.07 | ||||||
| EV/Sales LTM | x | 1.74 | 1.71 | ||||||
| Earnings Yield LTM | % | -3.96% | -4.58% | ||||||
| FCF Yield | % | +9.95% | +9.55% | ||||||
| Quality | |||||||||
| ROE | % | -4.55% | -5.21% | ||||||
| ROIC | % | +4.24% | +4.39% | ||||||
| Operating margin | % | +11.77% | +11.89% | ||||||
| Gross margin | % | +23.12% | +21.37% | ||||||
| FCF/Sales | % | +5.91% | +5.57% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +6.24% | +8.09% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -6.72% | -10.54% | ||||||
| Operating Profit Growth | % | +11.67% | +14.79% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.05 | 0.05 | ||||||
| Net Debt/EBITDA | x | 6.69 | 4.01 | ||||||
| EBIT/Net interest | x | 1.43 | 0.60 | ||||||
| Net debt/market cap | % | +1.43% | +1.91% | ||||||
| Net debt/Equity | x | 1.50 | 2.12 | ||||||
| Gross debt/equity | x | 2.35 | 2.40 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free